SporTRIA study-a multicentre trial protocol for excretion kinetics of triamcinolone acetonide following sport-related intra-articular injections in knees: definitions of the washout periods.
Fiche publication
Date publication
juin 2021
Journal
BMJ open
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ALBUISSON Eliane, Pr CHENUEL Bruno, Pr POUSSEL Mathias
Tous les auteurs :
Allado E, Poussel M, Gambier N, Saunier V, Starck M, Buisson C, Cinquetti G, Albuisson E, Chenuel B
Lien Pubmed
Résumé
Intra-articular (IA) and peri-articular glucocorticoid (GC) injections are common in sports medicine. However, from 1 January 2022, all injectable GC routes (including IA administration) will be prohibited in-competition by World Anti-Doping Agency (WADA). Owing to these rules, an IA GC treatment out-of-competition could result in an adverse analytical finding in-competition if the washout period is not clearly defined. The aim of this study is to determine the urinary excretion profile of triamcinolone acetonide following IA injection to strengthen the definition of the washout periods.
Mots clés
knee, rheumatology, sports medicine
Référence
BMJ Open. 2021 Jun 9;11(6):e047548